(Circulation. 1996;93:1388-1395.)
© 1996 American Heart Association, Inc.
Articles |
From the Division of Cardiology, St Michael's Hospital, Department of Medicine, University of Toronto, Ontario, Canada; Walter C. Mackenzie Health Sciences Centre, Department of Medicine, University of Alberta, Edmonton, Canada (P.W.A.); and the Division of Cardiology, George Washington University, Washington, DC (A.M.R.).
Correspondence to Dr Anatoly Langer, St Michael's Hospital, Division of Cardiology, 30 Bond St, Suite 701A, Toronto, Ontario, Canada M5B 1W8.
Background Diminished heart rate variability is associated with less favorable prognosis after myocardial infarction. However, the prognostic value of early (first 48 hours) measurement and the influence of thrombolytic strategies, myocardial infarction location, left ventricular function, ST-segment shift, and infarct-related artery patency on heart rate variability have not been examined comprehensively.
Methods and Results Heart rate variability and ST-segment analysis of 48-hour Holter tapes were performed with the use of a commercial system in 204 patients who were part of an ST-monitoring substudy of the Global Utilization of Streptokinase and TPA for Occluded Arteries (GUSTO-I) trial. Both time-domain measures (SD of the average normal RR interval for all 5-minute segments of a 24-hour ECG recording [SDANN] and percent difference between adjacent normal RR intervals >50 ms computed over the entire 24-hour ECG recording [pNN50]) and frequency-domain measures (low frequency [LF], high frequency [HF], and LF/HF ratio) were assessed on days 1 and 2 after acute myocardial infarction. Coronary angiography performed within the first 24 hours was also available in 75% of the patients. All heart rate variability measures decreased between day 1 and day 2 (P=.001) except the LF/HF ratio. There was no difference in heart rate variability among groups assigned to one of four different thrombolytic treatment strategies (streptokinase/subcutaneous heparin, streptokinase/intravenous heparin, accelerated tissue plasminogen activator, and combination streptokinase/tissue plasminogen activator). Heart rate variability measures were lower in anterior versus nonanterior infarcts (SDANN, 53±21 versus 63±24 ms; P<.005) and increased with TIMI grade 3 flow (LF, 5.3±1.0 versus 4.8±1.2 ms2; P<.01) and better ejection fraction (r=.2, P<.03). An inverse correlation between the duration of ST shift and frequency domain measures was observed (LF, r=-.2, P<.009; HF, r=-2, P<.03). Lower LF/HF ratio by 24 hours after myocardial infarction was seen in those who ultimately died at 30 days (1.0±0.2 versus 1.3±0.2, P<.001) or at 1 year (1.17±0.14 versus 1.26±0.19, P=.05).
Conclusions Changes in heart rate variability occurred early after thrombolysis and may be of prognostic value. Heart rate variability measures were improved in patients with better ejection fraction and greater angiographic patency. This suggests a possible mechanism for the enhanced survival observed with TIMI grade 3 flow in the GUSTO angiographic substudy. These data indicate that early heart rate variability assessment after myocardial infarction may be useful in noninvasive risk stratification.
Key Words: electrocardiography myocardial infarction heart rate prognosis
This article has been cited by other articles:
![]() |
G A Lanza, D Cianflone, A G Rebuzzi, G Angeloni, A Sestito, G Ciriello, G La Torre, F Crea, A Maseri, and for the Stratificazione Prognostica dell'Angina In Prognostic value of ventricular arrhythmias and heart rate variability in patients with unstable angina Heart, August 1, 2006; 92(8): 1055 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Eryonucu, K. Uzun, N. Guler, M. Tuncer, and C. Sezgi Comparison of the Short-term Effects of Salmeterol and Formoterol on Heart Rate Variability in Adult Asthmatic Patients Chest, September 1, 2005; 128(3): 1136 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Jardine, C. J. Charles, R. K. Ashton, S. I. Bennett, M. Whitehead, C. M. Frampton, and M. G. Nicholls Increased cardiac sympathetic nerve activity following acute myocardial infarction in a sheep model J. Physiol., May 15, 2005; 565(1): 325 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Richardson, A. Rozkovec, P. Thomas, J. Ryder, C. Meckes, and D. Kerr Influence of Caffeine on Heart Rate Variability in Patients With Long-Standing Type 1 Diabetes Diabetes Care, May 1, 2004; 27(5): 1127 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Glantz Air pollution as a cause of heart disease: Time for action J. Am. Coll. Cardiol., March 20, 2002; 39(6): 943 - 945. [Full Text] [PDF] |
||||
![]() |
B. Eryonucu, K. Uzun, N. Guler, and M. Bilge Comparison of the acute effects of salbutamol and terbutaline on heart rate variability in adult asthmatic patients Eur. Respir. J., May 1, 2001; 17(5): 863 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Leong, P. Mann, M. Wallymahmed, I. A. MacFarlane, and J. P. H. Wilding Abnormal Heart Rate Variability in Adults with Growth Hormone Deficiency J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 628 - 633. [Abstract] [Full Text] |
||||
![]() |
J. J. Goldberger Sympathovagal balance: how should we measure it? Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1273 - H1280. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |